Chinese Journal of Pharmacovigilance ›› 2023, Vol. 20 ›› Issue (1): 57-60.
DOI: 10.19803/j.1672-8629.20220328
Previous Articles Next Articles
XU Yingli, PANG Bo, CAO Shan, CHEN Mengping, SUN Jing, ZHAO Ronghua, ZHANG Jingsheng, ZHOU Lirun, WANG Yaxin, CUI Xiaolan*
Received:
2022-06-14
Published:
2023-01-19
CLC Number:
XU Yingli, PANG Bo, CAO Shan, CHEN Mengping, SUN Jing, ZHAO Ronghua, ZHANG Jingsheng, ZHOU Lirun, WANG Yaxin, CUI Xiaolan. Research progress in traditional Chinese medicines against multidrug-resistant Pseudomonas aeruginosa pneumonia[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 57-60.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.20220328
[1] KLEIN EY, VAN BTP, MARTINEZ EM, et al.Global increase and geographic convergence in antibiotic consumption between 2000 and 2015[J]. Proc Natl Acad Sci U S A, 2018, 115(15): E3463-E3470. [2] LEE J, ZHANG L.The hierarchy quorum sensing network in Pseudomonas aeruginosa[J]. Protein Cell, 2015, 6(1): 26-41. [3] HUA SY, YUAN SC, ZHOU YH, et al.Distribution and change of drug- resistant bacteria in severe pneumonia with different tcm syndromes[J]. Journal of Emergency in Traditional Chinese Medicine(中国中医急症), 2022, 31(8): 1152-1155. [4] YIN JT, ZHANG Y, LIANG MX, et al.Research progress of the therapeutic effect of traditional Chinese medicine on lung drug–resistant bacteria and its related mechanisms[J]. Journal of Shenyang Medical College(沈阳医学院学报), 2020 , 22(6): 575-578. [5] JIA LY, DENG D, SUN LH, et al.Mechanism of traditional Chinese medicine in treating drug-resistant bacterial infection[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2020, 26(16): 228-234. [6] DING YJ, XIE F, LIU XY, et al.Inhibition effect of Shuang huang lian injection on the bacteriostasis [7] ZHONG LY, LI RY.Bacteriostatic effect of berberine on [8] LIU F, GAO Y, JIANG HG, et al.Study of [9] GAO J, LIU QQ, TIAN JZ, et al.Effect of qiguiyin formula on imipenem-resisting pseudomonas aeruginosa[J]. Journal of Traditional Chinese Medicine(中医杂志), 2012, 53(16): 1408-1411. [10] SUGAWARA E, NAGANO K, NIKAIDO H.Alternative folding pathways of the major porin OprF of pseudomonas aeruginosa[J].FEBS J, 2012, 279(6): 910-918. [11] KUCHARSKA I, LIANG B, URSINI N, et al.Molecular interactions of Lipopolysaccharide with an Outer membrane protein from pseudomonas aeruginosa probed by solution NMR[J]. Biochemistry. 2016, 55(36): 5061-5072. [12] MASUDA N, SAKAGAWA E, Ohya S.Outer membrane proteins responsible for multiple drug resistance in pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1995, 39(3): 645-649. [13] JEANNOT K, ELSEN S, KÖHLER T, et al. Resistance and virulence of pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ ef?ux pump[J]. Antimicrob Agents Chemother. 2008, 52(7) : 2455-2462. [14] BISWAS R, PANJA AS, BANDOPADHYAY R.Molecular mechanism of antibiotic resistance: the untouched area of future hope[J]. Indian J Microbiol, 2019, 59(2) , 254-259. [15] WANG ZS.The effect of berberine on the efflux pump Mex AB-oprM of carbapenem resistant Pseudomonas aeruginosa[D]. Zheng zhou: Henan University of Chinese Medicine, 2020. [16] GUO W, ZHOU Y, YE L, et al.Studies of andrographolide on inhibiting MexAB-OprM efflux pump of Pseudomonas aeruginosa[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2010, 30(16): 1343-1347. [17] WANG YT,XU HR,ZHAO ST, et al.Effects of fuzheng jiedu huayu decoction on the expression of efflux pump mexab-oprm of multidrug-resistant pseudomonas aeruginosa[J]. World Chinese Medicine(世界中医药), 2019, 14(4): 859-863. [18] SAIPRIYA K, SWATHI CH, RATNAKAR KS, et al.Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development[J]. J Appl Microbiol, 2020, 128(1): 15-27. [19] XIE X,KONG JL,LUO J, et al.Research advances on the inhibitory effect of traditional Chinese medicine on drug-resistant bacteria biofilm[J]. The Journal of Practical Medicine(实用医学杂志), 2021, 37(21): 2813-2816. [20] EL-SAYED NR, SAMIR R, JAMIL M, et al.Olive leaf extract modulates quorum sensing genes and biofilm formation in multi-drug resistant pseudomonas aeruginosa[J]. Antibiotics (Basel),2020, 9(9): 526. [21] YANG W, WEI Q, TONG Q, et al.Traditional Chinese medicine tanreqing inhibits quorum sensing systems in pseudomon asaeruginosa[J]. Front Microbiol, 2020, 12(11): 517462. [22] WEI Q, BHASME P, WANG Z, et al.Chinese medicinal herb extract inhibits PQS-mediated quorum sensing system in Pseudomon asaeruginosa[J]. J Ethnopharmacol, 2020, 2(248): 112272. [23] WU D, HUANG W, DUAN Q, et al.Sodium houttuyfonate affects production of N-acyl homoserine lactone and quorum sensing-regulated genes expression in Pseudomonas aeruginosa[J]. Front Microbiol, 2014, 11(5): 635. [24] LUO J, DONG B, WANG K, et al.Baicalin inhibits biofilm formation,attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model[J]. PLoS One,2017, 12(4): e0176883. [25] WANG H, CHU W, YE C, et al.Chlorogenic acid attenuates virulence factors and pathogenicity of Pseudomonas aeruginosa by regulating quorum sensing[J]. Appl Microbiol Biotechnol, 2019, 103(2): 903-915. [26] GOLOVKINE G, FAUDRY E, BOUILLOT S, et al.Pseudomonas aeruginosa transmigrates at epithelial cell-cell junctions, exploiting sites of cell division and senescent cell extrusion[J]. Plos Pathog, 2016, 12(1): e1005377. [27] CAPASSO D, PEPE MV, ROSSELLO J, et al.Elimination of pseudomonas aeruginosa through efferocytosis upon binding to apoptotic cells[J]. Plos Pathog, 2016, 12(12): e1006068. [28] LIU MM, WANG Q, YANG J, et al.Diammonium glycyrrhizinate lipid ligand inhibits endotoxin induced inflammatory cell infiltration and cell junctional protein degradation in acute lung injury[J]. Chinese Journal of Histochemistry and Cytochemistry(中国组织化学与细胞化学杂志), 2017, 26(6): 546-553. [29] WANG Q.Protective effect and mechanism of chicory acid on endotoxin–induced acute lung injury in rats[J]. Journal of Mudanjiang Medical University(牡丹江医学院学报), 2022, 43(2): 5-9. [30] CUI WW, JIN X, ZHANG YF, et al.Effects of Lianhua Qingwen capsule on expression of inflammatory factors and connexin in lipopolysaccharide induced acute lung injury mice[J]. Chinese Journal of Pharmacology and Toxicology(中国药理学与毒理学杂志), 2015, 29(2): 213-219. [31] ZHU XJ, MA KF, HU LH, et al.Anti-inflammatory effects of beberine in Pseudomonas aeruginosa induce pneumonia in rat[J]. Chinese Journal of Nosocomiology(中华医院感染学杂志), 2020, 30(23): 3579-3583. [32] ZHANG D,YAN J,QIAN Y, et al.Effect and mechanism of fuzheng touxie prescription on immune homeostasis of drug-resistant pseudomonas aeruginosa lung infection rat[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2021, 27(24): 71-77. [33] WANG PY,FANG H,WU YG, et al.Regulation of matrine on Th1 /Th2 mechanism of Pseudomonas aeruginosa infected lung in rats[J]. Shanghai Journal of Traditional Chinese Medicine(上海中医药杂志), 2017, 51(7): 70-75. [34] WANG PY,FANG H.Quercetin improves pseudomonas aeruginosa-induced lung infection in rats[J]. Chinese Traditional Patent Medicine(中成药), 2017, 39(9): 1777-1782. [35] KONG LB, MA Q, GAO J, et al.Effect of Qiguiyin decoction on multidrug-resistant Pseudomonas aeruginosa infection in rats[J]. Chin J Integr Med, 2015, 21(12): 916-921. [36] LIU X, LYU JY, Li K, et al.The effects of Qing Re Hua Tan Tong Fu prescription on intestinal microflora in rats with cerebral infarction complicated with bacterial pneumonia[J]. Guangdong Medical Journal(广东医学), 2018, 39(13): 1942-1946. [37] LIU Z, WANG WJ, ZHU PC, et al.Regulatory effect of ginger juice on intestinal flora of LPS-induced pneumonia mice[J]. Food and Nutrition in China(中国食物与营养), 2020, 10(19): 1-8. [38] LI ZH, CHEN PP, WANG Y, et al.Effect of scutellaria baicalensis extract on intestinal microflora diversity in rats with heat syndrome based on high-throughput sequencing[J]. Chinese Traditional and Herbal Drugs(中草药), 2021, 52(2): 422-431. [39] Antimicrobial Resistance Collaborators.Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis[J]. Lancet, 2022, 399(10325): 629-655. |
[1] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[2] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[3] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[4] | CHEN Yuyan, ZHANG Mingxia, ZHANG Tao, ZHANG Jin. One case of interstitial pneumonia caused by serplulimab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 213-215. |
[5] | BAI Zhaofang, ZHAN Xiaoyan, YAO Qing, CHEN Simin, ZHAO Xu, XIAO Xiaohe. Theoretical innovation and technological breakthroughs in the safety evaluation of traditional Chinese medicine: disease-syndrome-based toxicology [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 6-14. |
[6] | GUO Longxin, GAO Yunjuan, WU Chengzhao, LONG Minjuan, ZHU Shengkai, SONG Haibo, ZHAO Xu, XIAO Xiaohe. Exploring new risk signals and susceptibility factors of traditional Chinese medicine-induced hepatotoxicity based on big data from adverse reaction monitoring [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 15-19. |
[7] | GAO Yuan, SHI Wei, XIAO Xiaohe, BAI Zhaofang, WANG Jiabo. Research progress on the animal models of idiosyncratic drug-induced liver injury [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 33-39. |
[8] | CAO Shan, PANG Bo, XU Yingli, ZHANG Jingsheng, CHEN Mengping, ZHANG Yu, WANG Yaxin, BAO Lei, GENG Zihan, GUO Shanshan, ZHAO Ronghua, CUI Xiaolan. Effects of Shufeng Jiedu capsules prophylactic administration on TLR4-mediated inflammatory injury in lung tissue in a mouse model of inffuenza virus infeciton [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 45-50. |
[9] | ZHANG Jingsheng, GAO Shuangrong, PANG Bo, LIU Lina, XU Yingli, CAO Shan, CHEN Mengping, ZHANG Yu, ZHAO Ronghua, CUI Xiaolan. The mechanism of Sanhan Huashi Granules on pneumonia induced by human coronavirus 229E and OC43 in mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 51-54. |
[10] | ZHANG Jingsheng, JI Zuen, PANG Bo, XU Yingli, CAO Shan, ZHANG Yu, SUN Qiyue, SUN Jing, LI Shuran, ZHANG Wei, ZHAO Ronghua, CUI Xiaolan. Discussion on traditional Chinese medicine theory and modern pharmacology of Xuanfei Baidu decoction for treating novel coronavirus infection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 55-58. |
[11] | LI Shuran, GUO Shanshan, JI Zuen, ZHANG Wei, CUI Xiaolan. Research status of cognitive dysfunction after SARS-CoV-2 infection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 59-64. |
[12] | ZHANG Li, WANG Yujia, ZHANG Lingling, CHEN Jiaxin, LIN Minhua, LIN Xiaohui, NIE Xuekun. Surveillance data on adverse reactions associated with real-world immune checkpoint inhibitors [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1035-1038. |
[13] | HE Jia, JIN Yan, ZHAO Yuyang, ZHOU Junhui, LI Xiaolin, YUAN Yuan, FU Lu. Research progress in methods for toxicity-decreasing processing of toxic herbal traditional Chinese medicines [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1064-1070. |
[14] | DING Zihe, ZHANG Yanqiong, LIN Na. Component-effect/toxicity-target correlations of Tripterygium wilfordii in terms of lipid metabolism [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 489-495. |
[15] | LIANG Shibing, YU Zeyu, KONG Lingyao, YAN Lijiao, HAN Mei, WU Jiarui, LIU Zhaolan, LIU Jianping. Applicability of bibliometric methods pharmacovigilance of traditioual Chinese medicine [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 591-594. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||